781 - 790 of 6514 Results
Title
Year
-
OPENTitle: Structure of the second phosphoubiquitin–binding site in parkinJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 7Start Page: 102114End Page: 102114Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jbc.2022.102114Best OA location URL: http://www.jbc.org/article/S0021925822005555/pdfCitation Count: 27
-
OPENTitle: 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page: 48End Page: 48Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00551-xBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00551-xCitation Count: 56
-
OPENTitle: Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signaturesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 30End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00282-2Best OA location URL: https://escholarship.org/uc/item/1jb2z7qrCitation Count: 46
- The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity2022OPENTitle: The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicityJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1083/jcb.202010065Best OA location URL: https://escholarship.org/uc/item/4764f6j3Citation Count: 18
-
OPENTitle: Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 11Start Page: e2121609119End Page: e2121609119Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2121609119Best OA location URL: https://escholarship.org/uc/item/4pt523rvCitation Count: 49
-
OPENTitle: A Novel Tissue Atlas and Online Tool for the Interrogation of Small RNA Expression in Human Tissues and BiofluidsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page: 804164End Page: 804164Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2022.804164Best OA location URL: https://doi.org/10.3389/fcell.2022.804164Citation Count: 16
-
OPENTitle: Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivoJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 3Issue #: 5Start Page: 100630End Page: 100630Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100630Best OA location URL: http://www.cell.com/article/S2666379122001550/pdfCitation Count: 31
-
OPENTitle: Explainable machine learning with pairwise interactions for the classification of Parkinson’s disease and SWEDD from clinical and imaging featuresJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 16Issue #: 5Start Page: 2188End Page: 2198Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11682-022-00688-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11682-022-00688-9.pdfCitation Count: 30
-
OPENTitle: Brain atrophy pattern in de novo Parkinson’s disease with probable RBD associated with cognitive impairmentJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 60End Page: 60Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00326-7Best OA location URL: https://www.nature.com/articles/s41531-022-00326-7.pdfCitation Count: 22
-
OPENTitle: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 61End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00322-xBest OA location URL: https://www.nature.com/articles/s41531-022-00322-x.pdfCitation Count: 9